Airway allergen exposure stimulates bone marrow eosinophilia partly via IL-9

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Sitkauskiene, Brigita ^a,b   Rådinger, Madeleine ^a   Bossios, Apostolos ^a   Johansson, Anna Karin ^a   Sakalauskas, Raimundas ^b   Lötvall, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BROXURIDINE; CD34 ANTIGEN; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 9; INTERLEUKIN 9 ANTIBODY; NEUTRALIZING ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CELL COUNT; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GRANULOPOIESIS; IMMUNOCYTOCHEMISTRY; LUNG LAVAGE; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; RANK SUM TEST; SINGLE DRUG DOSE; STAINING; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW DISEASE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; LOEFFLER PNEUMONIA; PATHOLOGY; RESPIRATORY TRACT ALLERGY;

ANIMALS; BONE MARROW CELLS; BONE MARROW DISEASES; INTERLEUKIN-5; INTERLEUKIN-9; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; RESPIRATORY HYPERSENSITIVITY;

EID: 25444444500     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-6-33     Document Type: Article

References (34)

1. Bousquet J, Chanez P, Lacoste YJ, Barneon G, Chavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990, 323:1033-1039.
2. Frigas E, Motojima S, Gleich GJ: The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J Suppl 1991:123s-135s.
3. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105:651-663.
4. Redington AE, Howarth PH: Airway wall remodeling in asthma. Thorax 1997, 52:310-312.
5. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996, 183:195-201.
6. Wang J, Palmer K, Lötvall J, Milan S, Lei XF, Matthaei KI, Gauldie J, Inman MD, Jordana M, Xing Z: Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998, 102:1132-1141.
7. 1. J Immunol 2000, 165:4040-4050.
8. + eosinophils by IL-5. Am J Respir Cell Mol Biol 2004, 30:367-378.
9. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J: Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leukoc Biol 1995, 57:353-360.
10. Van Snick J, Goethals A, Renauld JC, Van Roost E, Uyttenhove C, Rubira MR, Moritz RL, Simpson RJ: Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med 1989, 169:363-368.
11. Vink A, Warnier G, Brombacher F, Renauld JC: Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 1999, 189:1413-1423.
12. Bourette RP, Royet J, Mouchiroud G, Schmitt E, Blanchet JP: Murine interleukin 9 stimulates the proliferation of mouse erythroid progenitor cells and favours the erythroid differentiation of multipotent FDCP-mix cells. Exp Hematol 1992, 20:868-873.
13. Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K: IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003, 170:3461-3467.
14. Temann UA, Ray P, Flavell RA: Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002, 109:29-39.
15. McLane MP, Haczku A, van de Rijn M, Weiss K, Ferrante V, MacDonald D, Renauld JC, Nicolaides NC, Holroyd KJ, Levitt RC: Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol 1998, 19:713-720.
16. Levitt RC, McLane MP, MacDonald D, Ferrante V, Weiss C, Zhou T, Holroyd KJ, Nicolaides NC: IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 1999, 103(5 Pt 2):S485-S491.
17. Nicolaides NC, Holroyed KJ, Ewart SL, Eleff SM, Kiser MB, Dragwa CR, Sullivan CD, Grasso L, Zhang LY, Messler CJ, Zhou T, Kleeberger SR, Buetow KH, Levitt RC: Interleukin-9: a candidate gene for asthma. Proc Natl Acad Sci USA 1997, 94:13175-13180.
18. Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, Holgate T, Morton NE: Allergic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996, 153:1280-1284.
19. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, Krug N: Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003, 111:1319-1327.
20. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, Nicolaides NC, Holroyd KJ, Tsicopoulos A, Lafitte JJ, Wallaert B, Hamid QA: IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000, 105:108-115.
21. Bhathena PR, Comhair SA, Holroyd KJ, Enzurum SC: Interleukin-9 receptor expression in asthmatic airways in vivo. Lung 2000, 178:149-160.
22. Zhou Y, McLane M, Levitt RC: Interleukin-9 as a therapeutic target for asthma. Respir Res 2001, 2:80-84.
23. Gounni AS, Nutku E, Koussih L, Aris F, Louahed J, Levitt RC, Nicolaides NC, Hamid Q: IL-9 expression by human eosinophils: regulation by IL-1β and TNF-α. J Allergy Clin Immunol 2000, 106:460-466.
24. Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, North J, Tavernier J, Levit R, Nicolaides N, Robinson D, Hamid Q: Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000, 96:2163-2171.
25. Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, Vink A, Renauld JC, Van Snick J, Nicolaides NC, Levitt RC, Haczku A: Interleukin 9 promotes influx and local maturation of eosinophils. Blood 2001, 97:1035-1042.
26. + T cells from influenza virus-immune mice. Immunology 1998, 95:346-351.
27. Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, Fukushima F, Ishii Y, Fukuda T: Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002, 166:409-416.
28. Kung TT, Luo B, Crawley Y, Garlisi CG, Devito K, Minnicozzi M, Egan R, Kreutner W, Chapman RW: Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol 2001, 25:600-605.
29. McMillan S, Bishop B, Townsend MJ, McKenzie AN, Lloyd CM: The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med 2002, 195:51-57.
30. Johansson AK, Sergejeva S, Sjostrand M, Lee JJ, Lotvall J: Allergen-induced traffic of bone marrow eosinophils, neutrophils and lymphocytes to airways. Eur J Immunol 2004, 34:3135-3145.
31. Sergejeva S, Johansson AK, Malmhall C, Lotvall J: Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments. Blood 2004, 103:1270-1277.
32. Sehmi R, Howie K, Sutherland DR, Schragge W, O'Byrne PM, Denburg JA: Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 1996, 15:645-655.
33. Robinson DS, Damia R, Zeibecoglou K, Molet S, North J, Yamada T, Kay AB, Hamid Q: Presence of CD34+/IL-5+ eosinophil precursor cells in airways of asthmatic individuals. J Allergy Clin Immunol 1999, 103:9-13.
34. Abdelilah SG, Latifa K, Esra N, Lisa C, Bouchaib L, Nicolaides NC, Levitt RC, Hamid Q: Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol 2001, 166:2768-2774.